Hopes that colchicine could be re-purposed as a cheap anti-inflammatory for heart disease have been dashed by a pilot study showing it does not appear to significantly reduce hs-CRP levels after acute MI. “We all know that atherosclerosis is an inflammatory disease and that inflammation plays a key role in all stages of atherosclerosis, from ...
Hopes dashed for colchicine role in cardiovascular disease
By Nicola Garrett
20 Aug 2019